Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Mcl-1 is a novel therapeutic target for human sarcoma: synergistic inhibition of human sarcoma xenotransplants by a combination of mcl-1 antisense oligonucleotides with low-dose cyclophosphamideChristiane Thallinger, Markus F Wolschek, Helmut Maierhofer, et al.
Oncology Reports|May 24, 2008
Down-regulation of Mcl-1 with antisense technology alters the effect of various cytotoxic agents used in treatment of squamous cell carcinoma of the head and neckChristiane Skoda, Boban M Erovic, Volker Wachek, et al.
Histopathology|May 10, 2018
PD-1 and PD-L1 expression in HNSCC primary cancer and related lymph node metastasis - impact on clinical outcomeSven Schneider, Lorenz Kadletz, Robert Wiebringhaus, et al.
Head & Neck|March 5, 2004
Neoadjuvant radiochemotherapy of oral cavity and oropharyngeal cancer: evaluation of tumor response by CT differs from histopathologic response assessment in a significant fraction of patientsClemens Klug, David Keszthelyi, Oliver Ploder, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 13, 2005
The role of non-deletional tolerance mechanisms in a murine model of mixed chimerism with costimulation blockadeSinda Bigenzahn, Peter Blaha, Zvonimir Koporc, et al.
International Journal of Radiation Oncology, Biology, Physics|January 18, 2006
Tumor radiosensitizers--current status of development of various approaches: report of an International Atomic Energy Agency meetingMichael R Horsman, Lothar Bohm, Geoffrey P Margison, et al.
The Journal of Investigative Dermatology|June 6, 2003
Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation modelChristiane Thallinger, Markus F Wolschek, Volker Wacheck, et al.
Plos Currents|March 2, 2012
Phylogenetic discordance of human and canine carcinoembryonic antigen (CEA, CEACAM) families, but striking identity of the CEA receptors will impact comparative oncology studiesMarlene Weichselbaumer, Michael Willmann, Martin Reifinger, et al.
Cancer Research|April 4, 2002
The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanomaEdgar Selzer, Volker Wacheck, Trevor Lucas, et al.
Oncotarget|September 27, 2019
Correction: Fibroblast growth factor receptor 4 induced resistance to radiation therapy in colorectal cancerMohamed A Ahmed, Edgar Selzer, Wolfgang Dörr, et al.
Pageof 7